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Summary
Background. — B-type natriuretic peptide (BNP) and left atrial volume index (LAVi) are used
as surrogate measures for global myocardial function and are recommended for the diagnosis
of heart failure with normal ejection fraction. Little is known, however, about predictors in
patients with preserved systolic function.
Aims. — To identify factors that inﬂuence the relation of BNP and left atrial size to inva-
sively determined left ventricular end-diastolic pressure in stable patients with preserved left
ventricular systolic function.
Methods. — Fifty-nine consecutive patients were included prospectively. Clinical, biological,
Doppler echocardiographic and invasive variables were collected simultaneously.
Results. — BNP was predicted independently by left ventricular ejection fraction, diastolic
function and age (p < 0.05). LAVi was predicted independently by left ventricular mass index
and invasive left ventricular end-diastolic pressure (p < 0.01). BNP predicted increased left
ventricular end-diastolic pressure greater than 16mmHg (p = 0.004); the optimal cut-off value
Abbreviations: AUC, Area under the receiver-operating characteristic curve; BNP, B-type natriuretic peptide; HFnlEF, Heart failure
with normal ejection fraction; LAVi, Left atrial volume index.
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was 33 pg/mL (area under the receiver-operating characteristic curve [AUC] 0.74 [0.6—0.84],
p < 0.001, sensitivity 72%, speciﬁcity 70%). LAVi predicted increased left ventricular end-
diastolic pressure (p < 0.001); the optimal cut-off value for LAVi was 26mL/m2 (AUC 0.87
[0.75—0.94], p < 0.001; sensitivity 85%, speciﬁcity 80%). Unlike BNP (p = 0.1), LAVi performed
well in patients with abnormal relaxation at mitral ﬁlling (p < 0.01).
Conclusion. — BNP is inﬂuenced by age in stable patients with preserved systolic function and
should be interpreted cautiously. LAVi is a powerful surrogate for invasively determined left
ventricular end-diastolic pressure regardless of age and mitral ﬁlling.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte. — Le peptide natriurétique de type B (BNP) et le volume de l’oreillette gauche reﬂè-
tent la fonction myocardique globale et sont recommandés dans le diagnostic de l’insufﬁsance
cardiaque diastolique, mais leurs facteurs prédictifs sont peu connus en cas de fonction sys-
tolique préservée.
Objectifs. — Identiﬁer les facteurs inﬂuenc¸ant la corrélation de ces deux paramètres avec la
pression télédiastolique ventriculaire gauche chez les patients stables avec fonction systolique
préservée.
Méthodes. — Cinquante-neuf patients consécutifs ont été inclus de manière prospective.
Plusieurs données cliniques, biologiques, échographiques et invasives ont été collectées simul-
tanément.
Résultats. — Le BNP était indépendamment prédit par la fraction d’éjection, la fonction dias-
tolique et l’âge (p < 0,05). Le volume de l’oreillette gauche était indépendamment prédit par
la masse ventriculaire et la pression télédiastolique ventriculaire gauche invasive (p < 0,01).
Le BNP prédisait une élévation de la pression télédiastolique ventriculaire gauche supérieure
à 16mmHg (p = 0,004) ; la valeur seuil optimale était 33 pg/mL (aire sous la courbe ROC de
0,74 [0,6—0,84], p < 0,001, sensibilité 72 %, spéciﬁcité 70 %). L’oreillette gauche prédisait une
élévation de la pression télédiastolique ventriculaire gauche (p < 0,001) ; la valeur seuil opti-
male était 26mL/m2 (aire sous la courbe ROC de 0,87 [0,75—0,94], p < 0,001, sensibilité 85 %,
spéciﬁcité 80 %). À la différence du BNP (p = 0,1), l’oreillette gauche restait prédictive chez les
patients avec anomalie de relaxation au ﬂux Doppler mitral (p < 0,01).
Conclusion. — La concentration en BNP est inﬂuencée par l’âge chez les patients stables avec
fonction systolique préservée et doit être interprétée avec prudence. Le volume de l’oreillette
gauche est un puissant prédicteur de la pression télédiastolique ventriculaire gauche invasive
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ackground
FnlEF accounts for half of patients with the clinical syn-
rome of heart failure. Establishing this medical condition
s difﬁcult in daily clinical practice, although speciﬁc rec-
mmendations have been proposed recently by French and
uropean cardiology societies [1,2]. In particular, afﬁrma-
ion of HFnlEF is challenging in stable patients because
xertional symptoms are non-speciﬁc for the diagnosis
3,4]. Natriuretic peptides and left atrial size have been
elated successfully to invasively determined left ventric-
lar end-diastolic pressure —a well-recognized marker of
lobal myocardial dysfunction— and have been proposed
ubsequently for the diagnosis of HFnlEF in patients with
ormal ejection fraction [1,2]. However, these two vari-
bles are likely to be inﬂuenced by several confounders
nd little is known about factors affecting natriuretic
eptides and left atrial size in stable patients with pre-
erved left ventricular systolic function [5—7]. The aim
f the present study was to identify factors that inﬂu-
nce the relation of BNP and left atrial size to invasively
etermined left ventricular end-diastolic pressure in stable
e
t
m
r
pproﬁl mitral.
s droits réservés.
atients with preserved left ventricular systolic func-
ion.
ethods
atients
eventy-eight consecutive patients referred for clinically
ndicated catheterization were enrolled prospectively after
ritten informed consent was obtained. Patients had to
e in sinus rhythm, clinically stable and free of symptoms
nd signs of decompensated heart failure and symptomatic
oronary artery disease (including angina, acute coronary
yndromes and acute myocardial infarction) to be enrolled.
ll data (laboratory tests, Doppler echocardiography and
atheterization) were collected on the same morning for
ach patient. Patients with a left ventricular ejection frac-
ion less than 45%, severe left-sided valve disease and/or
ild to moderate mitral stenosis at Doppler echocardiog-
aphy were excluded. The ﬁnal study group comprised 59
atients.
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PNormal ejection fraction and predictors of BNP and left atri
Laboratory tests
A blood sample was collected from all the patients dur-
ing bed rest, early in the morning, to avoid the potential
inﬂuence of circadian variations and exercise on BNP
concentration [8,9], which was measured at our institu-
tion’s laboratory with an ADVIA Centaur system (Siemens
Healthcare Diagnostics Inc., Tarrytown, NY, USA; range of
5—5000 pg/mL). ADVIA Centaur BNP is harmonized to the
Biosite Triage assay with similar decision threshold values.
Serum creatinine and serum haemoglobin were measured
at the same time. Creatinine clearance (mL/min/m2) was
calculated with the Cockroft formula.
Doppler echocardiography
All patients underwent bedside Doppler echocardiography
with an Acuson Sequoia ultrasound system (Siemens, Moun-
tain View, CA, USA). All echocardiography measurements
were made by the same operator, who was blinded to
the data; the measurements were performed according to
recommendations from the American Society of Echocardio-
graphy [10] and validated by a second experienced operator.
Optimal Doppler gain and ﬁlter settings were adjusted care-
fully. Three to ﬁve beats were averaged for all variables.
Fractional shortening was measured in all patients. Left
ventricular ejection fraction was measured with Simpson’s
biplane method; Teichholz’s method was used in associ-
ation with a visual estimate in patients with inadequate
two-dimensional images in apical views. Peak early and late
diastolic mitral velocities (E and A, cm/s) were recorded
placing the pulsed-wave Doppler sample volume between
the tips of mitral leaﬂets. Diastolic function was catego-
rized according to mitral ﬁlling pattern and invasive data
as follows: normal mitral ﬁlling (E/A ratio 1—2 and normal
left ventricular end-diastolic pressure); abnormal relaxation
(E/A ratio < 1); pseudonormal mitral ﬁlling (E/A ratio 1—2
and increased left ventricular end-diastolic pressure); and
restrictive mitral ﬁlling (E/A ratio > 2 and increased left
ventricular end-diastolic pressure). The severity of mitral
regurgitation was assessed by the ﬂow convergence method.
The tissue Doppler-derived peak systolic s’ velocity was
measured by spectral tissue Doppler at the lateral side of
the mitral annulus and used as a surrogate for longitudi-
nal systolic function. The peak early diastolic e’ velocity
was measured by spectral tissue Doppler at the lateral
side of the mitral annulus and used as a surrogate for
left ventricular relaxation. The E/e’ ratio was calculated
and used as a non-invasive surrogate for instantaneous left
atrial pressure. Maximal left atrial volume was measured
at end-systole in the four-chamber apical view by Simpson’s
method and indexed to the body surface area (LAVi, mL/m2)
[11].
Invasive data
Baseline systolic aortic pressure and left ventricular end-
diastolic pressure were derived from left-sided heart
catheterization with a 4—6F ﬂuid-ﬁlled pigtail catheter. Five
consecutive beats were averaged at the end of expiration.
The presence of coronary artery disease at coronary angiog-
raphy was deﬁned as a stenosis greater than 70% in one or
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ore epicardial arteries, detected by two experienced oper-
tors. Increased left ventricular end-diastolic pressure was
eﬁned by a value greater than 16mmHg in this setting [2].
tatistical analysis
escriptive data are given as means± standard devia-
ions or medians [25th—75th percentiles] when appropriate.
og-transformed data were used for BNP concentrations.
ariables of inﬂuence were identiﬁed by multiple regression
nalysis. The multivariable model included only variables
hat reached signiﬁcance in the univariate model (i.e.
< 0.05), using a stepwise approach. The diagnostic per-
ormance of BNP, LAVi and E/e’ in predicting invasive left
entricular end-diastolic pressure greater than 16mmHg was
ssessed by logistic regression analysis. The diagnostic per-
ormance of variables was also evaluated using the area
nder the receiver-operating characteristic curve (AUC),
hich was provided with its 95% conﬁdence interval. The
ptimal cut-off corresponded to the value with the great-
st accuracy. A p-value less than 0.05 was considered to be
tatistically signiﬁcant. Medcalc statistical software (version
1.1.0, MedCalc Software, Mariakerke, Belgium) was used
or the purpose of statistical analysis.
esults
aseline clinical characteristics are summarized in Table 1.
ge ranged from 34—89 years. Five patients presented with
hronic kidney disease deﬁned by a creatinine clearance less
han 45mL/min/m2. Invasive left ventricular end-diastolic
ressure was increased in 39 patients (66%). BNP correlated
oorly with LAVi (r2 = 0.07, p = 0.036).
redictors of B-type natriuretic peptide
oncentration
y univariate analysis, BNP was predicted by age (p < 0.001),
ystolic blood pressure (p = 0.01), left ventricular ejec-
ion fraction (inverse relation, p < 0.001), s’ (inverse
elation, p = 0.01), E/e’ (p < 0.001), left ventricular mass
ndex (p = 0.001), mitral regurgitation (p < 0.001), indexed
eft ventricular end-diastolic diameter (p = 0.003), diastolic
unction (p = 0.004), invasive left ventricular end-diastolic
ressure (p < 0.001), creatinine clearance (inverse relation,
= 0.005), serum haemoglobin (inverse relation, p = 0.001)
nd diuretic therapy (p = 0.03), but not by sex, body mass
ndex, heart rate, fractional shortening, e’ or the extent of
oronary artery disease (Table 2).
By multivariable analysis, left ventricular ejection frac-
ion (inverse relation, p < 0.001), age (p = 0.003) and
iastolic function (p = 0.01) independently predicted BNP
Table 2).
redictors of left atrial volume indexy univariate analysis, LAVi was predicted by age (p = 0.006),
eft ventricular mass index (p < 0.001), mitral regurgitation
p = 0.02), left ventricular end-diastolic diameter (p = 0.02),
iastolic function (p = 0.006) and invasive left ventricular
nd-diastolic pressure (p < 0.001), but not by sex, systolic
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Table 1 Baseline characteristics of the study population (n = 59).
Variable
Age (years) 64± 12
Men 37 (63)
Systolic blood pressure (mmHg) 148± 31
Heart rate (beats/min) 65 [55—74]
Body mass index (kg/m2) 27± 5
New York Heart Association class 2± 0.7
Left ventricular ejection fraction (%) 59± 7
Fractional shortening (%) 34± 6
Tissue Doppler s’ velocity (cm/s) 9.4 [8—10]
Tissue Doppler e’ velocity (cm/s) 10.5 [9.4—12.5]
Tissue Doppler E/e’ ratio 6.6 [5.2—8.8]
Diastolic function
Normal 7 (12)
Impaired relaxation 28 (47)
Pseudonormal 21 (36)
Restrictive 3 (5)
Left ventricular mass index (g/m2) 92 [80—109]
Indexed left ventricular end-diastolic diameter (mm/m2) 27± 3.5
Left atrial volume index (mL/m2) 31 [22—39]
B-type natriuretic peptide concentration (pg/mL) 53 [20—137]
Medical history
Coronary artery disease 29 (49)
Hypertension 34 (58)
Diabetes mellitus 21 (36)
Dyslipidaemia 32 (54)
Pulmonary oedema 5 (9)
Chronic pulmonary disease 9 (15)
Chronic medication
Diuretic 20 (34)
Beta-blocker 35 (59)
ACE inhibitor/ARB 40 (68)
Invasive left ventricular end-diastolic pressure (mm Hg) 20± 7
Coronary artery disease 30 (51)
One vessel 11 (19)
Two vessels 8 (14)
Three vessels 11 (19)
Serum haemoglobin (g/dL) 12.8± 1.7
Creatinine clearance (mL/min) 85 [68—108]
Data are means± standard deviations, medians [25th—75th percentiles] or numbers (%).
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lood pressure, heart rate, body mass index, left ventric-
lar ejection fraction, s’, e’, E/e’, fractional shortening,
he extent of coronary artery disease, creatinine clearance,
erum haemoglobin or treatment (Table 2).
By multivariable analysis, invasive left ventricular
nd-diastolic pressure (p = 0.001) and left ventricular
ass index (p = 0.005) independently predicted LAVi
Table 2).
iagnostic accuracy of B-type natriuretic peptide
nd left atrial volume index in predicting increased
eft ventricular end-diastolic pressure
he E/e’ ratio predicted increased left ventricular end-
iastolic pressure (odds ratio 1.4 [1.07—1.9], p = 0.01).
(
e
p
c
pr.
he optimal cut-off value for E/e’ was 6.7 (AUC 0.69
0.56—0.80], p < 0.01, sensitivity 56%, speciﬁcity 80%). Log
BNP) correlated well with left ventricular end-diastolic
ressure (r = 0.50 [0.28—0.67], p < 0.001) (Fig. 1). BNP was
good predictor of increased left ventricular end-diastolic
ressure (odds ratio 5.0 [1.7—15.0], p = 0.004). The opti-
al cut-off value was 33 pg/mL (AUC 0.74 [0.6—0.84],
< 0.001, sensitivity 72%, speciﬁcity 70%). The cut-off value
f 100 pg/mL was 46% sensitive and 80% speciﬁc. LAVi cor-
elated well with left ventricular end-diastolic pressure
r = 0.48 [0.25—0.65], p < 0.001) (Fig. 2). LAVi was a pow-
rful predictor of increased left ventricular end-diastolic
ressure (odds ratio 1.19 [1.09—1.3], p < 0.001). The optimal
ut-off value for LAVi was 26mL/m2 (AUC 0.87 [0.75—0.94],
< 0.001; sensitivity 85%, speciﬁcity 80%).
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Table 2 Multiple regression analysis of factors affecting B-type natriuretic peptide and left atrial volume index.
Variable B-type natriuretic peptide Left atrial volume index
Univariate
analysis p-value
Multivariable
analysis p-value
Univariate
analysis p-value
Multivariable
analysis p-value
Age < 0.001 0.003 0.006 NS
Sex 0.07 - 0.22 -
Body mass index 0.52 - 0.06 -
Systolic blood pressure 0.01 NS 0.21 -
Heart rate 0.78 - 0.33 -
Left ventricular
ejection fraction
< 0.001 < 0.001 0.1 -
Tissue Doppler s’
velocity
0.01 NS 0.19 -
Tissue Doppler e’
velocity
0.09 - 0.34 -
Tissue Doppler E/e’
ratio
< 0.001 NS 0.07 -
Fractional shortening 0.62 - 0.7 -
Left ventricular mass
index
0.001 NS < 0.001 0.005
Indexed left ventricular
diastolic diameter
0.003 NS 0.02 NS
Mitral regurgitation < 0.001 NS 0.02 NS
Diastolic function 0.004 0.01 0.006 NS
Invasive left ventricular
end-diastolic
pressure
< 0.001 NS < 0.001 0.001
Extent of coronary
artery disease
0.09 - 0.58 -
Diuretics 0.03 NS 0.08 -
Beta-blockers 0.23 - 0.19 -
ACE inhibitor/ARB 0.2 - 0.52 -
Creatinine clearance 0.005 NS 0.67 -
Serum haemoglobin 0.001 NS 0.33 -
ACE: angiotensin-converting enzyme; ARB: angiotensin receptor blocker; NS: not signiﬁcant (p > 0.05); -: not entered into the
multivariable model.
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aComparison of ROC curves showed that LAVi performed
better than E/e’ (p = 0.015) and that BNP performed as well
as E/e’ (p = 0.5). The difference between BNP and LAVi did
not reach statistical signiﬁcance (p = 0.06).
Diagnostic accuracy of B-type natriuretic peptide
and left atrial volume index in predicting increased
left ventricular end-diastolic pressure in patients
with abnormal relaxation
Twenty-eight patients presented with abnormal relaxation
at mitral ﬁlling pattern, of whom 15 had increased left ven-
tricular end-diastolic pressure.
Unlike E/e’ (p = 0.1) and BNP (p = 0.1), LAVi was predictive
of increased left ventricular end-diastolic pressure (odds
ratio 1.2 [1.05—1.4], p = 0.007). The optimal cut-off value
for LAVi was 24mL/m2 (AUC 0.91 [0.74—−0.98], p < 0.001;
sensitivity 93%, speciﬁcity 85%).
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siscussion
o our knowledge, this is the ﬁrst study to compare pre-
ictors of BNP and LAVi, two well-recognized markers of
ardiac dysfunction, in a population of patients with pre-
erved systolic function and invasive data. As expected, BNP
nd LAVi were not impacted similarly, which accounts for the
oor correlation that has been observed between these two
ariables.
Along with invasively determined left ventricular end-
iastolic pressure, several factors have been identiﬁed
hat inﬂuence natriuretic peptide concentrations [12—19]:
ge, body mass index, left ventricular systolic function,
iastolic wall stress, renal function and serum haemoglobin.
ur data suggest that, along with systolic and diastolic
unction, ageing impacts on BNP concentration signiﬁ-
antly and independently in stable patients with preserved
ystolic function. This suggests that this clinical variable
hould be taken into consideration before interpreting BNP
8Figure 1. Scatterplot of the relationship between log-
transformed data for B-type natriuretic peptide (log [BNP])
and invasively measured left ventricular end-diastolic pres-
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iure (LVEDP). The correlation coefﬁcient was 0.50 [0.28—0.67]
p < 0.001). The solid line corresponds to the regression line
LVEDP = 6.1× log [BNP] + 10.2) and the dotted lines correspond to
ts 95% conﬁdence interval.
oncentration in this setting [20] and that further studies
re necessary to delineate the diagnostic relevance of
atriuretic peptides in speciﬁc age groups. Furthermore,
n the present study, in a large proportion (90%) of patients
ith invasive left ventricular end-diastolic pressure greater
han 16mmHg, BNP concentrations were lower than the
tandard threshold value of 200 pg/mL proposed currently
n European recommendations [2]. This observation is con-
istent with studies published previously, which reported
nexpectedly low BNP concentrations (< 100—200 pg/mL)
n stable patients with HFnlEF [21,22]. However, there was
igure 2. Scatterplot of the relationship between left atrial
olume index (LAVi) and invasively measured left ventricular end-
iastolic pressure (LVEDP). The correlation coefﬁcient was 0.48
0.25—0.65] (p < 0.001). The solid line corresponds to the regression
ine (LVEDP = 0.26× LAVi + 11.8) and the dotted lines correspond to
ts 95% conﬁdence interval.
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o invasive evidence of this medical condition in any of
hese studies. Our results highlight in patients with invasive
aemodynamics that threshold values for the diagnosis
f HFnlEF should be established according to clinical
resentation (i.e. stable vs decompensated state) [2,7].
In the present study, LAVi reﬂected invasively deter-
ined left ventricular end-diastolic pressure strongly
nd independently in stable patients with preserved left
entricular systolic function. This ﬁnding conﬁrms those of
tudies published previously, which included predominantly
atients with depressed left ventricular systolic function
23,24]. Left ventricular hypertrophy per se impacts on left
trial size, which may explain in part the poor correlation
etween left atrial volume and left ventricular diastolic
ressures in hypertrophic cardiomyopathy [25]. Increased
eft ventricular end-diastolic pressure at rest is a landmark
f severe left ventricular dysfunction, and subsequently
f HFnlEF in symptomatic patients with preserved systolic
unction [2]. Previous studies have established the value of
eft atrial size for the prediction of prevalent [26—28] and
ncident [29,30] HFnlEF; however, invasive haemodynamics
ere not available in any of these works. As a straightfor-
ard consequence of current literature and the present
tudy, LAVi can be used safely as part of a multiparametric
pproach for the diagnosis of HFnlEF in stable patients,
egardless of age and mitral ﬁlling [2].
tudy limitations
here are some limitations in the present study. The number
f patients is relatively small, although statistically signif-
cant results have been achieved. However, patients with
ymptomatic coronary artery disease were not included in
he study group because active ischaemia is likely to impact
n BNP concentration. Simpson’s biplane method was not
sed for assessing left atrial volume because the anterior
all of the left atrium is sometimes difﬁcult to delineate
learly. Furthermore, it has been established that the single
lane method is clinically relevant for daily practice [11].
onclusion
NP and LAVi, which are synonymous with ‘glycosylated
aemoglobin’ in terms of global myocardial function, are
ot affected similarly in stable patients with preserved left
entricular systolic function. While BNP is inﬂuenced by age,
AVi is a robust surrogate for invasively determined left ven-
ricular end-diastolic pressure, regardless of age and mitral
lling. Therefore, LAVi can be used safely for the diagnosis
f HFnlEF in stable patients.
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